Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.5720
-0.0417 (-6.79%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $7.95 million as of June 12, 2026. Its market cap has decreased by -45.80% in one year.
Market Cap
7.95M
Enterprise Value
18.11M
1-Year Change
-45.80%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $7.95M, a decrease of -92.32%. That is a compound annual growth rate of -37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 7.95M | -56.44% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 12.16M |
| Nexalin Technology | 9.72M |
| Sintx Technologies | 9.55M |
| Phaos Technology Holdings (Cayman) Limited | 9.21M |
| IceCure Medical | 7.25M |
| Tenon Medical | 7.04M |
| enVVeno Medical | 6.83M |
| Biomerica | 6.46M |